Cardiokol
Voice-based Markers for Large-scale Monitoring and Screening of Heart Rhythm Disorders
StartupCardiokol is a "-based startup in the Health Tech & Life Sciences sector, established in 2017. Voice-based Markers for Large-scale Monitoring and Screening of Heart Rhythm Disorders. The company has raised a total of $8M across 2 funding rounds, currently at the Seed stage. Cardiokol was founded by Alon Goren, Eli Attar, Pini Sabach. Key investors include Kamet Ventures, KYTO. The company has 1-10 employees. Core technologies: Artificial Intelligence, Machine Learning, Voice & Speech Recognition, Semiconductors & Electronics, Digital Signal Processor.
With $8M in total funding, Cardiokol is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageSeed
- ProductReleased
- ModelB2B
- Employees1-10
- HQ"
- Last Round$8M
- Kamet VenturesLead
- KYTO
Alon GorenCo-founder & Executive ChairmanEli AttarCo-founder, COO, VP R&D and Board Member
Pini SabachCo-founder, Chief Collaborations & Cyber Security Officer
2 articles covered by sources including www.tech12.co.il,
www.mobihealthnews.com.
What does Cardiokol do?
Cardiokol is a privately owned digital telehealth company that develops voice-based markers and methods for monitoring and screening heart rhythm disorders in large at-risk populations. The company utilizes proprietary technology that is implemented in speech platforms such as landlines, smart phones, smart speakers, and voice assistants. Cardiokol offers low-cost, long-term, and user-friendly monitoring solutions, applicable for monitoring at-risk populations of older adults (65+).
How much funding has Cardiokol raised?
Cardiokol has raised $8M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Kamet Ventures, KYTO.
Who founded Cardiokol?
Cardiokol was founded in 2017 by Alon Goren (Co-founder & Executive Chairman), Eli Attar (Co-founder, COO, VP R&D and Board Member), Pini Sabach (Co-founder, Chief Collaborations & Cyber Security Officer).
What sector is Cardiokol in?
Cardiokol operates in Health Tech & Life Sciences, Digital Healthcare, Patient Remote Monitoring, with core technologies in Artificial Intelligence, Machine Learning, Voice & Speech Recognition, Semiconductors & Electronics, Digital Signal Processor. Target customers: Consumers, Demographics & Family, Seniors, Healthcare & Life Sciences, Healthcare, Providers.
Where is Cardiokol located?
Cardiokol is based in Airport City, Israel.